Email Checker & Verification Tool
Verify potential customers' email addresses for increased open rates.
Bristol-Myers Squibb Company Information
Contact Information
headquarters:
phone:
website:
www.bms.comrevenue:
stock Symbol:
number Of Employees:
Popular Searches
Industries
Manufacturing|Business Services|Manufacturing|Pharmaceuticals|Research & Development
Bristol-Myers Squibb Top Competitors And Email Format
Show email address
Show email address
Show email address
Show email address
Similar Companies to Bristol-Myers Squibb
Frequently Asked Questions
What does Bristol-Myers Squibb employee email looks like?
The most used employees email address of Bristol-Myers Squibb is John.Smith@bms.com, being used 87.4% of the time.
What is Bristol-Myers Squibb email format?
Bristol-Myers Squibb common email format is John.Smith@bms.com, being used 87.4% of the time. Other email formats include JSmith@bms.com.
How can I check Bristol-Myers Squibb email address is validated?
Validating Bristol-Myers Squibb email can be done by using NeverBounce, a product that helps you verify and clean email lists easily and automatically.
What is Bristol-Myers Squibb email domain?
Bristol-Myers Squibb email domain is bms.com.
How can I reduce email bounce for Bristol-Myers Squibb company?
Email bounce rate for Bristol-Myers Squibb email addresses can be reduced using NeverBounce. NeverBounce has special logic that produces accurate results.
What is the email format for Bristol-Myers Squibb competition?
Bristol-Myers Squibb top competitors include Pfizer Inc, GlaxoSmithKline PLC, Eisai Co. Ltd, AbbVie Inc.
What industry does Bristol-Myers Squibb belongs to?
Bristol-Myers Squibb is in the industry of Manufacturing, and also Business Services, Manufacturing.
What does Bristol-Myers Squibb do?
Bristol-Myers Squibb Company discovers, develops, licenses, manufactures, markets, and distributes biopharmaceutical products worldwide. The company offers chemically-synthesized drug and biologic in various therapeutic areas, such as oncology; cardiovascular; immunoscience; and virology comprising human immunodeficiency virus infection (HIV). Its products include Empliciti, a humanized monoclonal antibody to treat multiple myeloma; Opdivo, a human monoclonal antibody to treat renal cell carcinoma, non-small cell lung cancer, classical Hodgkin lymphoma, gastric cancer, melanoma, metastatic urothelial carcinoma, and squamous cell carcinoma of the head and neck; Erbitux, an IgG1 monoclonal antibody that blocks the epidermal growth factor receptor; Sprycel, a tyrosine kinase inhibitor for the treatment of adults with Philadelphia chromosome-positive chronic myeloid leukemia; and Yervoy, a monoclonal antibody for metastatic melanoma. The companys products also comprise Eliquis, an oral factor Xa inhibitor targeted at stroke prevention in atrial fibrillation; Baraclude to treat chronic hepatitis B virus; Daklinza and Sunvepra to treat hepatitis C virus (HCV); Reyataz and Sustiva to treat HIV; Abilify, an antipsychotic agent for adults with schizophrenia, bipolar mania disorder, and depressive disorder; Beclabuvir, a non-nucleoside NS5B inhibitor for the treatment of HCV; and Orencia to treat rheumatoid arthritis. It has collaboration agreements with Portola Pharmaceuticals, Inc., Apexigen, Inc., and Nordic Bioscience; clinical research collaborations with Array BioPharma, Novartis, Clovis Oncology, Inc., and Daiichi Sankyo; and license agreement with Nitto Denko Corporation to develop and commercialize siRNA molecules targeted at HSP47 in vitamin A. The company was formerly known as Bristol-Myers Company and changed its name to Bristol-Myers Squibb Company in 1989. Bristol-Myers Squibb Company was founded in 1887 and is headquartered in New York.